| JYHB2200188 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2022-04-08 | | Novartis Pharma Schweiz AG | | | view |
| JXHL1100356 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2011-10-18 | | Glaxo Group Ltd | Certificate Issued | 2015-02-12 | view |
| JYHB2101244 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2021-07-09 | | Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| JYHB2400518 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-01 | | Novartis Pharma Schweiz AG | | | view |
| JYHZ2100622 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | License Renew | 2021-09-16 | | Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| JXHL1000257 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2010-09-09 | | Glaxo Group Ltd | Certificate Issued | 2011-10-14 | view |
| JYHB2101243 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2021-07-09 | | Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| CYHB2302363 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-10-25 | | Shanghai Acebright Pharmaceuticals Co Ltd;Jiangsu Yahong Meditech Co Ltd | | | view |
| CYHS2501775 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Generic Drug | 2025-05-15 | | Jiangsu Huayang Pharmaceutical Co Ltd;Jiangsu Huaxin Pharmaceutical Co Ltd | | | view |
| JYHZ2100621 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | License Renew | 2021-09-16 | | Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| CYHS2302309 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Generic Drug | 2023-08-30 | | Shandong Langnuo Pharmaceutical Co Ltd | | | view |
| CYHS2200235 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Generic Drug | 2022-01-29 | | CSPC OUYI Pharmaceutical Co Ltd | | | view |
| JXHL1000266 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2010-09-03 | | Glaxo Group Ltd | Certificate Issued | 2011-10-14 | view |
| JYHB2101056 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2021-04-23 | | Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| JYHB2200187 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2022-04-08 | | Novartis Pharma Schweiz AG | | | view |
| JXHL1100355 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2011-10-20 | | Glaxo Group Ltd | Certificate Issued | 2015-02-12 | view |
| JYHB2101057 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2021-04-23 | | Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| CYHB2401853 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-11-09 | | Kunshan Rotam Reddy Pharmaceutical Co Ltd;Shandong Langnuo Pharmaceutical Co Ltd | | | view |
| JXHS1500047 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2015-05-08 | Glaxo Group Limited | Glaxo Group Ltd;Glaxo Operations UK Ltd | Certificate Issued | 2017-02-28 | view |
| JXHS1500046 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2015-05-08 | Glaxo Group Limited | Glaxo Group Ltd;Glaxo Operations UK Ltd | Certificate Issued | 2017-02-28 | view |
